← Leaderboards
Larisa Y Poluektova
University Of Nebraska Medical Center
$9,010,153
Attributed
$16,269,388
Total exposure
17
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$16,269,388 · 17
By mechanism
R01$7,851,420 · 4
R24$3,234,988 · 1
R21$2,031,090 · 4
P20$1,790,116 · 7
R33$1,361,774 · 1
Top collaborators
- Santhi Gorantla12 shared
- Natalia Aleksandr Osna8 shared
- Howard Eliot Gendelman5 shared
- Channabasavaiah Gurumurthy4 shared
- Benson Edagwa3 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Natalia Aleksandr Osna$4,604,885
- Benson Edagwa$6,144,379
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionCellsImmuneMacrophageViralHiv-1Pharmaceutical PreparationsImmune ResponseAnimal ModelVirus DiseasesHematopoietic Stem CellsAnimalsImmunityMouse ModelFundingLiverVirusHepatocyteBrainAnti-Retroviral AgentsResearch PersonnelResourcesAffectLymphoid Tissue
Grant awards (38)
New generation of long acting nucleos(t)ides and immune stimulant for treatment of chronic hepatitis B$611,174
R01 · FY2024 · AI · contact PI
New generation of long acting nucleos(t)ides and immune stimulant for treatment of chronic hepatitis B$611,174
R01 · FY2023 · AI · contact PI
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol$516,042
R01 · FY2023 · AA
Enhancement of Human Immune System Development in Mouse Models$191,875
R21 · FY2023 · OD · contact PI
New generation of long acting nucleos(t)ides and immune stimulant for treatment of chronic hepatitis B$610,511
R01 · FY2022 · AI · contact PI
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol$513,541
R01 · FY2022 · AA
Enhancement of Human Immune System Development in Mouse Models$230,250
R21 · FY2022 · OD · contact PI
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol$525,723
R01 · FY2021 · AA
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol$515,878
R01 · FY2020 · AA · contact PI
Development of humanized transgenic mice for HBV/HIV co-infection studies$190,625
R21 · FY2020 · AI · contact PI
Humanized Mice as a Tool to Monitor HIV Brain Reservoirs and Effects of Substance Abuse$680,887
R33 · FY2019 · DA
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol$529,043
R01 · FY2019 · AA · contact PI
Development of humanized transgenic mice for HBV/HIV co-infection studies$451,591
R21 · FY2019 · AI · contact PI
Humanized Mice as a Tool to Monitor HIV Brain Reservoirs and Effects of Substance Abuse$680,887
R33 · FY2018 · DA
Center for Humanized Mice$744,154
R24 · FY2017 · OD · contact PI
SMART HAND$625,779
R01 · FY2017 · AG
Center for Humanized Mice$363,960
R24 · FY2017 · OD · contact PI
Humanized Mice as a Tool to Monitor HIV Brain Reservoirs and Effects of Substance Abuse$188,128
R21 · FY2017 · DA · contact PI
Center for Humanized Mice$746,325
R24 · FY2016 · OD · contact PI
SMART HAND$625,779
R01 · FY2016 · AG
Humanized Mice as a Tool to Monitor HIV Brain Reservoirs and Effects of Substance Abuse$186,246
R21 · FY2016 · DA · contact PI
Center for Humanized Mice$692,358
R24 · FY2015 · OD · contact PI
SMART HAND$607,005
R01 · FY2015 · AG
Humanized Mice as a Tool to Monitor HIV Brain Reservoirs and Effects of Substance Abuse$188,125
R21 · FY2015 · DA · contact PI
Center for Humanized Mice$688,191
R24 · FY2014 · OD · contact PI
SMART HAND$625,779
R01 · FY2014 · AG
SMART HAND$625,779
R01 · FY2013 · AG
ANTI-VIRAL PEPTIDE NANOCOMPLEXES (APN) FOR TREATMENT OF HIV/HCV CO-INFECTION$236,734
P20 · FY2011 · RR · contact PI
SIV, IDO, and the Host Response in neuroAIDS$308,213
R01 · FY2010 · MH · contact PI
ANTI-VIRAL PEPTIDE NANOCOMPLEXES (APN) FOR TREATMENT OF HIV/HCV CO-INFECTION$225,335
P20 · FY2010 · RR · contact PI
IMMUNE MODULATION AND RESTORATION IN HIV-1 INFECTION$66,915
P20 · FY2009 · RR · contact PI
SUBTYPE C HIV VACCINE TESTING IN HUMANIZED MICE$284,022
P20 · FY2008 · RR · contact PI
Humanized mice for Neuro AIDS$183,750
R21 · FY2008 · NS · contact PI
SUBTYPE C HIV VACCINE TESTING IN HUMANIZED MICE$275,110
P20 · FY2007 · RR · contact PI
Humanized mice for Neuro AIDS$220,500
R21 · FY2007 · NS · contact PI
NEURODEGENERATION AND NEURORESTITUTION IN MURINE HIV-1 ENCEPHALITIS$302,175
P20 · FY2006 · RR · contact PI
NEURODEGENERATION/NEURORESTITUTION--HIV-1 ENCEPHALITIS$175,897
P20 · FY2005 · RR
NEURODEGENERATION AND NEURORESTITUTION IN MURINE HIV-1 ENCEPHALITIS$223,928
P20 · FY2004 · RR